These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15033447)

  • 41. Status epilepticus alters zolpidem sensitivity of [3H]flunitrazepam binding in the developing rat brain.
    Laurén HB; Lopez-Picon FR; Kukko-Lukjanov TK; Uusi-Oukari M; Holopainen IE
    Neuroscience; 2007 May; 146(2):802-11. PubMed ID: 17360122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural characterization of GABARAP-ligand interactions.
    Thielmann Y; Weiergräber OH; Mohrlüder J; Willbold D
    Mol Biosyst; 2009 Jun; 5(6):575-9. PubMed ID: 19462014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular dynamics investigation of Cl(-) transport through the closed and open states of the 2α12β2γ2 GABA(A) receptor.
    Xie HB; Wang J; Sha Y; Cheng MS
    Biophys Chem; 2013; 180-181():1-9. PubMed ID: 23771165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital.
    Drafts BC; Fisher JL
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1094-101. PubMed ID: 16728592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling.
    Lager E; Andersson P; Nilsson J; Pettersson I; Nielsen EØ; Nielsen M; Sterner O; Liljefors T
    J Med Chem; 2006 Apr; 49(8):2526-33. PubMed ID: 16610795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A structure-based QSAR and docking study on imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4,]benzodiazepines as Selective GABA(A) α5 inverse agonists.
    Gharaghani S; Khayamian T; Keshavarz F
    Chem Biol Drug Des; 2011 Oct; 78(4):612-21. PubMed ID: 21756285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Better cure for anxiety, sleep disorders, epilepsy?].
    Korpi ER; Wisden W; Lüddens H
    Lakartidningen; 1997 Sep; 94(39):3403-8. PubMed ID: 9379810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure.
    Goddard WA; Kim SK; Li Y; Trzaskowski B; Griffith AR; Abrol R
    J Struct Biol; 2010 Apr; 170(1):10-20. PubMed ID: 20079848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homology modeling and atomic level binding study of GABA(A) receptor with novel enaminone amides.
    Cheng J; Ju XL
    Eur J Med Chem; 2010 Sep; 45(9):3595-600. PubMed ID: 20684859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benzodiazepine-induced hyperphagia: development and assessment of a 3D pharmacophore by computational methods.
    Filizola M; Harris DL; Loew GH
    J Biomol Struct Dyn; 2000 Apr; 17(5):769-78. PubMed ID: 10798522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist.
    Li X; Cao H; Zhang C; Furtmueller R; Fuchs K; Huck S; Sieghart W; Deschamps J; Cook JM
    J Med Chem; 2003 Dec; 46(26):5567-70. PubMed ID: 14667209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homology model of the GABAA receptor examined using Brownian dynamics.
    O'Mara M; Cromer B; Parker M; Chung SH
    Biophys J; 2005 May; 88(5):3286-99. PubMed ID: 15749776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding modes of noncompetitive GABA-channel blockers revisited using engineered affinity-labeling reactions combined with new docking studies.
    Charon S; Taly A; Rodrigo J; Perret P; Goeldner M
    J Agric Food Chem; 2011 Apr; 59(7):2803-7. PubMed ID: 20839772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A fragment of recombinant GABA(A) receptor alpha1 subunit forming rosette-like homo-oligomers.
    Xue H; Zheng H; Li HM; Kitmitto A; Zhu H; Lee P; Holzenburg A
    J Mol Biol; 2000 Feb; 296(3):739-42. PubMed ID: 10677277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
    Huang Q; He X; Ma C; Liu R; Yu S; Dayer CA; Wenger GR; McKernan R; Cook JM
    J Med Chem; 2000 Jan; 43(1):71-95. PubMed ID: 10633039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a 3D pharmacophore for nonspecific ligand recognition of alpha1, alpha2, alpha3, alpha5, and alpha6 containing GABA(A)/benzodiazepine receptors.
    Filizola M; Harris DL; Loew GH
    Bioorg Med Chem; 2000 Jul; 8(7):1799-807. PubMed ID: 10976528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GABA
    Has ATC; Chebib M
    Curr Pharm Des; 2018; 24(17):1839-1844. PubMed ID: 29766792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular biology of the GABA(A) receptor: functional domains implicated by mutational analysis.
    Davies M; Bateson AN; Dunn SM
    Front Biosci; 1996 Sep; 1():d214-33. PubMed ID: 9159229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of the stable conformation of GABA(A)-benzodiazepine receptor bivalent ligands by low temperature NMR and X-ray analysis.
    Han D; Försterling FH; Li X; Deschamps JR; Cao H; Cook JM
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1465-9. PubMed ID: 15006383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anxiety over GABA(A) receptor structure relieved by AChBP.
    Cromer BA; Morton CJ; Parker MW
    Trends Biochem Sci; 2002 Jun; 27(6):280-7. PubMed ID: 12069787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.